World Courier has extended its network in China to 36 major cities, enabling the company to offer cold chain transport services for biological specimens, investigational drugs and supplies to every clinical trial location currently approved by the Chinese State Food & Drug Administration.
Temperature-controlled shipments can now be handled directly between the following cities: Beijing, Changchun, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Jinan, Kunming, Lanzhou, Lhasa, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyun, Tianjin, Urumqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Zhengzhou and Zhuhai.
According to Henning Voss, World Courier’s director, North Asia, China is poised to become the fourth largest pharmaceutical market by 2012.
“China presents many infrastructure challenges for temperature-controlled and clinical trial shipments,” says Voss. “Domestic transport companies do not yet fully understand the many international standards at play in handling these types of shipments. As such, the real concerns and requirements of major pharmaceutical clients in China have not been adequately addressed until now.”
With the establishment of World Courier's new domestic network in China all temperature-sensitive pharmaceutical and clinical trial shipments are handled by trained personnel according to established SOPs and IATA transportation standards. Only validated packaging complete with industry-accepted cold-pack mediums and temperature recording devices are used.